Covidien launches site on bariatric's benefits

Share this article:
Medical device and surgical manufacturer Covidien has launched a website to educate patients and physicians on the benefits of bariatric surgery as a treatment for Type 2 diabetes.

The site, www.bariatrics4diabetes.com, includes testimonials from patients, procedural details and the pros and cons of gastric band versus gastric bypass, data points on the surgery's efficacy in curing diabetes, and a surgeon locator. Partnering surgeons for the site's locator are recruited at trade shows, and through Covidien's sales organization, explained Jason Whitney, partner at Rosetta, an interactive agency that built the website with Covidien. “Surgical devices are not top-of-mind when you think about patient marketing,” said Whitney. “Bariatrics4diabetes is [Covidien's] first significant foray into patient marketing.”

In addition to connecting patients with surgeons, the site asks visitors to sign up for an email newsletter. From there, potential patients are asked a series of questions to identify key motives and barriers for more efficient communication. “We're constantly testing which aspects of our content, messaging and offerings are most relevant to specific patient segments,” said Rob Claypoole, director of marketing, at Covidien. 
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?